Articles

• Segelov, E, et al, Practical considerations for treating cancer patients in the COVID-19 pandemic, JCO Oncology (published online 13 May 2020)
• Weinkove, R, et al, Managing haematology and oncology patients during the COVID-19 pandemic: interim consensus guidance, Medical Journal of Australia (published online 1 June 2020)

Wiley has a free online library of articles they have published related to COVID-19

• Milch, V, et al, Cancer Australia consensus statement on COVID‐19 and cancer care: embedding high value changes in practice, Medical Journal of Australia (published online 25 October 2021)
• Navarro, D F, et al, Clinical care of children and adolescents with COVID‐19: recommendations from the National COVID‐19 Clinical Evidence Taskforce, Medical Journal of Australia (published online 25 October 2021)
• Breen, K E, et al, Factors Influencing Patient Preferences for Telehealth Cancer Genetic Counseling During the COVID-19 Pandemic, JCO Oncology Practice (published online 15 October 2021)
• Kaufman, H W, et al, Patterns of Prostate-Specific Antigen Testing and Prostate Biopsies During the COVID-19 Pandemic, JCO Clinical Cancer Informatics (published online 14 October 2021)
• Charla, Y, et al, COVID-19 vaccination in pediatric cancer patients: A high priority, Pediatric Blood & Cancer (published online 11 October 2021)
• Garreffa, E, et al, Regional lymphadenopathy following COVID-19 vaccination: Literature review and considerations for patient management in breast cancer care, European Journal of Cancer (published online 10 October 2021)
• Takada, K, et al, Reasons to Consider the COVID-19 Vaccination Status of Patients With Cancer When Analyzing Their COVID-19 Outcomes, Journal of Clinical Oncology (published online 8 October 2021)
• Caffo, O, Severe acute respiratory syndrome coronavirus 2 infection in patients with prostate cancer: A critical review, Critical Reviews in Oncology/Hematology (published online 6 October 2021)
• Lee, A, et al, Efficacy of COVID-19 vaccines in immunocompromised patients: A systematic review and meta-analysis, medRxiv (published online 1 October 2021)
• Mair, M J, et al, Humoral Immune Response in Hematooncological Patients and Health Care Workers Who Received SARS-CoV-2 Vaccinations, JAMA Oncology (published online 30 September 2021)
• Shroff, R T, et al, Immune responses to two and three doses of the BNT162b2 mRNA vaccine in adults with solid tumors, Nature Medicine (published online 30 September 2021)
• Grinshpun, A, et al, Serologic response to COVID-19 infection and/or vaccine in cancer patients on active treatment, ESMO Open Cancer Horizons (published online 26 September 2021)
• Pilishvili, T, et al, Effectiveness of mRNA Covid-19 Vaccine among US Health Care Personnel, New England Journal of Medicine (published online 22 September 2021)
• Fox, T A, et al, Low seropositivity and suboptimal neutralisation rates in patients fully vaccinated against COVID-19 with B-cell malignancies, British Journal of Haematology (published online 21 September 2021)
• Cavanna, L, et al, COVID-19 Vaccines in Cancer Patients. Seropositivity and Safety. Systematic Review and Meta-Analysis, Vaccines (published online 20 September 2021)
• Edge, R, et al, Cancer care disruption and reorganisation during the COVID-19 pandemic in Australia: A patient, carer and healthcare worker perspective, PLOS ONE (published online 17 September 2021)
• Zojer, N, et al, SARS-CoV-2 vaccination in patients with solid tumors or hematological malignancies: Is the pandemic over for fully vaccinated patients? Magazine of European Medical Oncology (published online 16 September 2021)
• Kotecha, R S, COVID-19 vaccination for children with cancer, Pediatric Blood & Cancer (published online 14 September 2021)
• Hesary, F B, Salehiniya, H, The Impact of the COVID-19 Epidemic on Diagnosis, Treatment, Concerns, Problems, and Mental Health in Patients with Gastric Cancer, Journal of Gastrointestinal Cancer (published online 14 September 2021)
• Gundavda, M K, Gundavda, K K, Cancer or COVID-19? A Review of Recommendations for COVID-19 Vaccination in Cancer Patients, Current Treatments Options in Oncology (published online 13 September 2021)
• Roy, S, et al, Outcome of COVID-19 in Solid Organ Malignancies: Experience From a Tertiary Cancer Center in Eastern India, JCO Global Oncology (published online 10 September 2021)
• Zomerdijk, N, et al, Experiences and needs of people with haematological cancers during the COVID-19 pandemic: A qualitative study, Psycho-Oncology (published online 9 September 2021)
• Bennett, C M, Learning to live with COVID-19 in Australia: time for a new approach, Public Health Research Practice (published online 8 September 2021)
• Nutbeam, D, Recovering from a punch in the mouth – the need for continuous adaptation to COVID-19, Public Health Research and Practice (published online 8 September 2021)
• Desai, A, et al, COVID-19 and Cancer: A Review of the Registry-Based Pandemic Response, JAMA Oncology (published online 2 September 2021)
• Islam, J Y, et al, Evaluating Mental Health–Related Symptoms Among Cancer Survivors During the COVID-19 Pandemic: An Analysis of the COVID Impact Survey, JCO Oncology Practice (published online 1 September 2021)
• Daly, B, et al, Oncology Patients’ Perspectives on Remote Patient Monitoring for COVID-19, JCO Oncology Practice (published online 1 September 2021)
• Teckie, S, et al, Impact of the COVID-19 Pandemic Surge on Radiation Treatment: Report From a Multicenter New York Area Institution, JCO Oncology Practice (published online 1 September 2021)
• Thakkar, A, et al, COVID-19 Vaccine among Actively-Treated People with Cancer: A Glimpse into the Known Unknowns? Journal of the National Cancer Institute (published online 28 August 2021)
• Lemos, A E G, et al, Susceptibility of lung cancer patients to COVID-19: A review of the pandemic data from multiple nationalities, Thoracic Oncology (published online 26 August 2021)
• Mukkada, S, et al, Global characteristics and outcomes of SARS-CoV-2 infection in children and adolescents with cancer (GRCCC): a cohort study, The Lancet Oncology (published online 26 August 2021)
• Sun, P, et al, Breast reconstruction during the COVID-19 pandemic, Medicine (published online 20 August 2021)
• Bhatia, V, et al, Systemwide Advance Care Planning During the Covid-19 Pandemic: The Impact on Patient Outcomes and Cost, NEJM Catalyst Innovations in Care Delivery (published online 18 August 2021)
• Nadkarni, A R, et al, Mortality in Cancer Patients With COVID-19 Who Are Admitted to an ICU or Who Have Severe COVID-19: A Systematic Review and Meta-Analysis, JCO Oncology Practice (published online 18 August 2021)
• Scales, D, et al, The Covid-19 Infodemic — Applying the Epidemiologic Model to Counter Misinformation, New England Journal of Medicine (published online 18 August 2021)
• Hanley, M J, et al, The health system response to COVID-19 will continue long after we reach 80% vaccination coverage, Medical Journal of Australia (preprint 17 August 2021)
• Henry, D A, et al, Effectiveness of COVID‐19 vaccines: findings from real world studies, Medical Journal of Australia (published online 16 August 2021)
• Mark, C, et al, Safety of administration of BNT162b2 mRNA (Pfizer-BioNTech) COVID-19 vaccine in youths and young adults with a history of acute lymphoblastic leukemia and allergy to PEG-asparaginase, Pediatric Blood & Cancer (published online 16 August 2021)
• Wark, P B A, et al, We are not doing enough to prevent the spread of COVID‐19 and other respiratory viruses in Australian hospitals, Medical Journal of Australia (published online 16 August 2021)
• Eliakim-Raz, N, et al, Durability of Response to SARS-CoV-2 BNT162b2 Vaccination in Patients on Active Anticancer Treatment, JAMA Oncology (published online 11 August 2021)
• Ollila, T A, et al, Antibody Response to COVID-19 Vaccination in Adults With Hematologic Malignant Disease, JAMA Oncology (published online 11 August 2021)
• Williams, E L, et al, Taking Tele Behind the Scenes: Remote Clinical Trial Monitoring Comes of Age During the COVID-19 Pandemic, JCO Oncology Practice (published online 11 August 2021)
• Moroni, M, and Bruera, E, Caregiver Exclusion in Fighting Cancer During COVID-19: Splitting the Risk, Doubling the Team, Journal of Clinical Oncology (published online 10 August 2021)
• Griffiths, E A, Segal, B H, Immune responses to COVID-19 vaccines in patients with cancer: Promising results and a note of caution, Cancer Cell (published online 9 August 2021)
• Lopez-Leon, S, et al, More than 50 long-term effects of COVID-19: a systematic review and meta-analysis, Scientific Reports (published online 9 August 2021)
• Watson, L, et al, Virtual Cancer Care During the COVID-19 Pandemic in Alberta: Evidence From a Mixed Methods Evaluation and Key Learnings, JCO Oncology Practice (published online 5 August 2021)
• Tang, M, et al, Changes in systemic cancer therapy in Australia during the COVID-19 pandemic: a population-based study, The Lancet Regional Health – Western Pacific (published online 3 August 2021)
• Satish, T, et al, Care Delivery Impact of the COVID-19 Pandemic on Breast Cancer Care, JCO Oncology Practice (published online 1 August 2021)
• Mac, O A, et al, Coronavirus (COVID-19) vaccination information must pay attention to health literacy: analysis of readability of official COVID-19 public health information, Medical Journal of Australia (preprint 29 July 2021)
• Perumalswami, C R, et al, “I'm Being Forced to Make Decisions I Have Never Had to Make Before”: Oncologists' Experiences of Caring for Seriously Ill Persons With Poor Prognoses and the Dilemmas Created by COVID-19, JCO Oncology Practice (published online 29 July 2021)
• Gerber, D E, et al, Longitudinal Experience With and Impressions of COVID-19–Related Clinical Research Changes, JCO Oncology Practice (published online 29 July 2021)
• Bergwerk, M, et al, Covid-19 Breakthrough Infections in Vaccinated Health Care Workers, New England Journal of Medicine (published online 28 July 2021)
• Sinha, S, Kundu, C N, Cancer and COVID-19: Why are cancer patients more susceptible to COVID-19?, Medical Oncology (published online 24 July 2021)
• Hampshire, A, et al, Cognitive deficits in people who have recovered from COVID-19, The Lancet EClinicalMedicine (published online 22 July 2021)
• Seidler, A L, et al, The landscape of COVID‐19 trials in Australia, Medical Journal of Australia (published online 19 July 2021)
• Nachega, J B, et al, Scaling Up Covid-19 Vaccination in Africa – Lessons from the HIV Pandemic, New England Journal of Medicine (published online 15 July 2021)
• Frenck, R W, et al, Safety, Immunogenicity, and Efficacy of the BNT162b2 Covid-19 Vaccine in Adolescents, New England Journal of Medicine (published online 15 July 2021)
• O’Hayer, V, et al, Behavioral Health for the Front Line: Lessons from the Covid-19 Pandemic, NEJM Catalyst Innovations in Care Delivery (published online 14 July 2021)
• Sharafeldin, N, et al, Outcomes of COVID-19 in Patients With Cancer: Report From the National COVID Cohort Collaborative (N3C), Journal of Clinical Oncology (published online 10 July 2021)
• Goshen-Lago, T, et al, Serologic Status and Toxic Effects of the SARS-CoV-2 BNT162b2 Vaccine in Patients Undergoing Treatment for Cancer, JAMA Oncology (published online 8 July 2021)
• Mandal, A, et al, Vaccination of cancer patients against COVID-19: towards the end of a dilemma, Medical Oncology (published online 8 July 2021)
• Marta, G N, et al, Outcomes and Prognostic Factors in a Large Cohort of Hospitalized Cancer Patients With COVID-19, JCO Global Oncology (published online 6 July 2021)
• Jiwnani S, et al, COVID-19 Pandemic and Its Gendered Impact on Indian Physicians, JCO Global Oncology (published online 6 July 2021)
• Kevat, D A S, et al, Medico‐legal considerations of mandatory COVID‐19 vaccination for high risk workers, Medical Journal of Australia (published online 5 July 2021)
• Leask, J, et al, Communicating with patients and the public about COVID‐19 vaccine safety: recommendations from the Collaboration on Social Science and Immunisation, Medical Journal of Australia (published online 5 July 2021)
• Kevat, D A S, et al, Medico‐legal considerations of mandatory COVID‐19 vaccination for high risk workers, Medical Journal of Australia (published online 5 July 2021)
• Hlubocky, F J, et al, Impact of the COVID-19 Pandemic on Oncologist Burnout, Emotional Well-Being, and Moral Distress: Considerations for the Cancer Organization’s Response for Readiness, Mitigation, and Resilience, JCO Oncology Practice (published online 1 July 2021)
• McCabe, H M, et al, What Matters to Us: Impact of Telemedicine During the Pandemic in the Care of Patients With Sarcoma Across Scotland, JCO Global Oncology (published online 30 June 2021)
• Tan, H, et al, COVID-19 did not delay time from referral to definitive management for head and neck cancer patients in a regional Victorian centre, ANZ Journal of Surgery (published online 29 June 2021)
• He, Y, et al, COVID-19 vaccine development from the perspective of cancer patients, Human Vaccines & Immunotherapeutics (published online 25 June 2021)
• Ratzan, S, et al, Missing the Point — How Primary Care Can Overcome Covid-19 Vaccine “Hesitancy”, New England Journal of Medicine (published online 24 June 2021)
• Zomerdijk, N, et al, Prevalence and correlates of psychological distress, unmet supportive care needs, and fear of cancer recurrence among haematological cancer patients during the COVID-19 pandemic, Supportive Care in Cancer (published online 23 June 2021)
• Smith, H, et al, Principles for pandemics: COVID-19 and professional ethical guidance in England and Wales, BMC Medical Ethics (published online 24 June 2021)
• Fleetwood, J, Motherhood and medicine in the time of COVID‐19, Medical Journal of Australia (published online 21 June 2021)
• Addeo, A, et al, Immunogenicity of SARS-CoV-2 messenger RNA vaccines in patients with cancer, Cancer Cell (published online 18 June 2021)
• Shimabukuro, T T, et al, Preliminary Findings of mRNA Covid-19 Vaccine Safety in Pregnant Persons, New England Journal of Medicine (published online 17 June 2021)
• Xu, R, et al, Online Public Interest in Cancer During the COVID-19 Pandemic, JCO Clinical Cancer Informatics (published online 17 June 2021)
• Sun, L, et al, SARS-CoV-2 Seropositivity and Seroconversion in Patients Undergoing Active Cancer-Directed Therapy, JCO Oncology Practice (published online 16 June 2021)
• Villarreal-Garza, C, et al, Attitudes and Factors Associated With COVID-19 Vaccine Hesitancy Among Patients With Breast Cancer, JAMA Oncology (published online 10 June 2021)
• O’Hayer, C V, et al, Behavioral Health for the Front Line: Lessons from the Covid-19 Pandemic, NEJM Catalyst Innovation in Care Delivery (published online 9 June 2021)
• Indini, A, et al, COVID-19 Vaccination in Patients with Classic Kaposi’s Sarcoma, Vaccines (published online 10 June 2021)
• Nguyen, N P, et al, COVID-19 Vaccination among minority Cancer Patients: Recommendation of the International Geriatric Radiotherapy group, Archives of Clinical and Biomedical Research (published online 7 June 2021)
• Thakker, A, et al, Seroconversion rates following COVID-19 vaccination among patients with cancer, Cancer Cell (published online 5 June 2021)
• Daly, B, et al, Oncology Patients' Perspectives on Remote Patient Monitoring for COVID-19, JCO Oncology Practice (published online 4 June 2021)
• Saleh, G, et al, Nutrition in Cancer Patients Positive for COVID-19; Case Series and a Systematic Review of Literature, Nutrition and Cancer (published online 3 June 2021) (Full access subscribers only)
• Trapani, D, & Curigliano, G, COVID-19 vaccines in patients with cancer, The Lancet Oncology (published online 1 June 2021) 
• Powis, M, et al, Impact of the early phase of the COVID pandemic on cancer treatment delivery and the quality of cancer care: a scoping review and conceptual model, International Journal for Quality in Health Care (published online 1 June 2021)
• Costa, B, & Vale, N, A Review of Repurposed Cancer Drugs in Clinical Trials for Potential Treatment of COVID-19, Pharmaceutics (published online 30 May 2021)
• Travers, A, et al, Business as unusual: medical oncology services adapt and deliver during COVID-19, Internal Medicine Journal (published online 27 May 2021)
• Ranganathan P, et al, Impact of COVID-19 on cancer care in India: a cohort study, The Lancet Oncology (published online 27 May 2021)
• Schiappacasse, G, Ethical Considerations in Chemotherapy and Vaccines in Cancer Patients in Times of the COVID-19 Pandemic, Current Oncology (published online 26 May 2021)
• Ahmed, M E, et al, Patient Satisfaction of Telemedicine Visits in an Advanced Prostate Cancer Clinic During the COVID-19 Pandemic, Mayo Clinic Proceedings (published online 26 May 2021)
• Di Noia, V, et al, The first report on coronavirus disease 2019 (COVID-19) vaccine refusal by patients with solid cancer in Italy: Early data from a single-institute survey, European Journal of Cancer (published online 26 May 2021)
• Ong, W L, & Weerasinghe, C, Radiation oncology training in Australia and New Zealand during and beyond the COVID-19 pandemic – lessons learnt and opportunities for improvement, Journal of Medical Imaging and Radiation Oncology (published online 25 May 2021) 
• Close, E, et al, Transparent triage policies during the COVID‐19 pandemic: a critical part of medico‐legal risk management for clinicians, Medical Journal of Australia (published online 24 May 2021)
• Curigliano, G, & Eggermont, A M M, Adherence to COVID-19 vaccines in cancer patients: promote it and make it happen! European Journal of Cancer (published online 24 May 2021)
• Haustead, D, et al, Clinical course and care requirements during the 2020 COVID‐19 epidemic in South Australia, Medical Journal of Australia (published online 24 May 2021)
• Gupta, N, et al, Impact of COVID-19 on Outcomes for Patients With Cervical Cancer in India, JCO Global Oncology (published online 17 May 2021)
• Perin, D M P, et al, Interruption of cancer screening services due to COVID-19 pandemic: lessons from previous disasters, Preventive Medicine Reports (published online 17 May 2021)
• Vazquez Rosas, T, et al, Social Distancing and Economic Crisis During COVID-19 Pandemic Reduced Cancer Control in Latin America and Will Result in Increased Late-Stage Diagnoses and Expense, JCO Global Oncology (published online 17 May 2021)
• Zong, Z, et al, The intersection of COVID-19 and cancer: signaling pathways and treatment implications, Molecular Cancer (published online 17 May 2021)
• Korompoki, E, et al, COVID-19 Vaccines in Patients With Cancer—A Welcome Addition, but There Is Need for Optimization, JAMA Oncology (published online 13 May 2021)
• Batterham, P, et al, Trajectories of depression and anxiety symptoms during the COVID‐19 pandemic in a representative Australian adult cohort, Medical Journal of Australia (published online 10 May 2021)
• Ayubi, E, et al, Depression and Anxiety Among Patients with Cancer During COVID-19 Pandemic: A Systematic Review and Meta-analysis, Journal of Gastrointestinal Cancer (published online 5 May 2021)
• Lei, H, et al, Higher mortality in lung cancer patients with COVID-19? A systematic review and meta-analysis, Lung Cancer (published online 5 May 2021)
• Poh Loh, K, et al, COVID-19 vaccines in older adults with cancer: a Young International Society of Geriatric Oncology perspective, The Lancet Healthy Longevity (published online 1 May 2021)
• Brower, K J, et al, The Evolving Role of the Chief Wellness Officer in the Management of Crises by Health Care Systems: Lessons from the Covid-19 Pandemic, NEJM Catalyst Innovations in Care Delivery (May 2021)
• Oliu-Barton, M, et al, SARS-CoV-2 elimination, not mitigation, creates best outcomes for health, the economy, and civil liberties, The Lancet (published online 28 April 2021)
• Monin, L, et al, Safety and immunogenicity of one versus two doses of the COVID-19 vaccine BNT162b2 for patients with cancer: interim analysis of a prospective observational study, The Lancet Oncology (published online 27 April 2021)
• Yusuf, A, et al, Cancer and COVID-19 vaccines: a complex global picture, The Lancet Oncology (published online 27 April 2021)
• Sasisekharan, R, Preparing for the Future – Nanobodies for Covid-19? New England Journal of Medicine (published online 22 April 2021)
• Shimabukuro, T T, et al, Preliminary Findings of mRNA Covid-19 Vaccine Safety in Pregnant Persons, New England Journal of Medicine (published online 22 April 2021)
• SteelFisher, G K, et al, An Uncertain Public — Encouraging Acceptance of Covid-19 Vaccines, New England Journal of Medicine, (published online 22 April 2021)
• Cavalieri, S, et al, Monitoring patients with head and neck cancer for flu-like symptoms during the COVID-19 pandemic, Tumori Journal (published online 13 April 2021)
• Issaka, R B, et al, Model-Based Estimation of Colorectal Cancer Screening and Outcomes During the COVID-19 Pandemic, JAMA Network Open (published online 12 April 2021)
• Aznab, M, et al, Value of influenza vaccines in cancer patients during the coronavirus (COVID-19) pandemic: a cross-sectional study, Supportive Care in Cancer (published online 10 April 2021)
• Kadakia, K T, et al, Virtual Clinical Trials in Oncology—Overview, Challenges, Policy Considerations, and Future Directions, JCO Clinical Cancer Informatics (published online 8 April 2021)
• Morgan, G, et al, OncoAlert Round Table Discussions: The Global COVID-19 Experience, JCO Global Oncology (published online 6 April 2021)
• Taquet, M, et al, 6-month neurological and psychiatric outcomes in 236,379 survivors of COVID-19: a retrospective cohort study using electronic health records, The Lancet Psychiatry (published online 6 April 2021)
• Wadasadawala, T, et al, Multinational Study to Assess Stress Levels Among the Health Care Workers of Radiation Oncology Community at the Outset of the COVID-19 Pandemic, JCO Global Oncology (published online 6 April 2021)
• Wehrle, C J, et al, Patient and Physician Attitudes Toward Telemedicine in Cancer Clinics Following the COVID-19 Pandemic, JCO Clinical Cancer Informatics (published online 6 April 2021)
• López-Fernández, A, et al, Patients’ and professionals’ perspective of non-in-person visits in hereditary cancer: predictors and impact of the COVID-19 pandemic, Genetics in Medicine (published online 6 April 2021)
• Ives, A, et al, Resilience and ongoing quality care for cancer clinical trials during COVID‐19: Experience from a tertiary hospital in Australia, Asia-Pacific Journal of Clinical Oncology (published online 5 April 2021)
• Motton, S, et al, Evaluation of the impact of the COVID-19 lockdown on the quality of life of patients monitored for cancer who practice an adapted physical activity: rugby for health, Journal of Cancer Research and Clinical Oncology (published online 5 April 2021)
• Basu, P, et al, Cancer Screening in the Coronavirus Pandemic Era: Adjusting to a New Situation, JCO Global Oncology (published online 30 March 2021)
• Alewine, C, et al, Caregiver Exclusion in the Age of COVID: Fighting Cancer With Half the Team, Journal of Clinical Oncology (published online 29 March 2021)
• Hauk, H, et al, Breaking bad news to cancer patients in times of COVID-19, Supportive Care in Cancer (published online 29 March 2021)
• To, N, et al, COVID-19 restrictions on multidisciplinary team meeting decision-making: service evaluation in a major UK cancer centre, British Journal of Surgery (published online 29 March 2021)
• Knoerl, R, et al, Lessons learned from the delivery of virtual integrative oncology interventions in clinical practice and research during the COVID-19 pandemic, Supportive Care Cancer (published online 26 March 2021)
• Hulbert-Williams, NJ, et al, Evaluating the impact of COVID-19 on supportive care needs, psychological distress and quality of life in UK cancer survivors and their support network, European Journal of Cancer Care (published online 25 March 2021)
• Lee, A J X, and Purshouse, K, COVID-19 and cancer registries: learning from the first peak of the SARS-CoV-2 pandemic, British Journal of Cancer (published online 25 March 2021)
• COVIDSurg Collaborative, GlobalSurg Collaborative, SARS-CoV-2 vaccination modelling for safe surgery to save lives: data from an international prospective cohort study, British Journal of Surgery (published online 24 March 2021)
• Grossheim, L, et al, Cancer and COVID-19 Experiences at African Cancer Centers: The Silver Lining, JCO Global Oncology (published online 24 March 2021)
• Ivanyi, P, et al, Protective measures for patients with advanced cancer during the Sars-CoV-2 pandemic: Quo vadis? Clinical & Experimental Metastasis (published online 23 March 2021)
• Gurney, J, et al, The impact of the COVID-19 pandemic on cancer diagnosis and service access in New Zealand-a country pursuing COVID-19 elimination, The Lancet Regional Health, Western Pacific (published online 22 March 2021)
• Desai, A, et al, COVID-19 vaccine guidance for patients with cancer participating in oncology clinical trials, Nature Reviews Clinical Oncology (published online 15 March 2021)
• Mangoni, A A, Erre, G L, Translating evidence into practice during the COVID-19 pandemic: pitfalls and mileages, Therapeutic Advances in Drug Safety (published online 15 March 2021)
• Meena, J P, et al, Clinical presentations and outcomes of children with cancer and COVID‐19: A systematic review, Pediatric Blood & Cancer (published online 15 March 2021)
• Edge, R, et al, Psychosocial impact of COVID-19 on cancer patients, survivors, and carers in Australia: a real-time assessment of cancer support services, Supportive Care in Cancer (published online 11 March 2021)
• Pacheco, R L, et al, Impact of Strategies for Mitigating Delays and Disruptions in Cancer Care Due to COVID-19: Systematic Review, JCO Global Oncology (published online 3 March 2021)
• Corti, C, et al, SARS-CoV-2 vaccines for cancer patients: a call to action, European Journal of Cancer (published online 24 February 2021)
• Riera, R, et al, Delays and Disruptions in Cancer Health Care Due to COVID-19 Pandemic: Systematic Review, JCO Global Oncology (published online 22 February 2021)
• Fu, J, et al, Evaluation and characterization of HSPA5 (GRP78) expression profiles in normal individuals and cancer patients with COVID-19, International Journal of Biological Sciences (published online 18 February 2021)
• Klass, P, and Ratner A J, Vaccinating Children against Covid-19 — The Lessons of Measles, New England Journal of Medicine (published online 18 February 2021)
• Libster, R, et al, Early High-Titer Plasma Therapy to Prevent Severe Covid-19 in Older Adults, New England Journal of Medicine (published online 18 February 2021)
• Pritchard-Jones, K, et al, The threat of the COVID-19 pandemic on reversing global life-saving gains in the survival of childhood cancer: a call for collaborative action from SIOP, IPSO, PROS, WCC, CCI, St Jude Global, UICC and WHPCA, ecancer (published online 15 February 2021)
• Burbury, K, et al, Telehealth in cancer care: during and beyond the COVID‐19 pandemic, Internal Medicine Journal (published online 11 February 2021)
• Jazieh, A R, et al, Impact of the COVID-19 Pandemic on Oncologists: Results of an International Study, JCO Global Oncology (published online 11 February 2021)
• Cornberg, M, et al, EASL position paper on the use of COVID-19 vaccines in patients with chronic liver diseases, hepatobiliary cancer and liver transplant recipients, Journal of Hepatology (published online 6 February 2021)
• Webb, G J, et al, Age and comorbidity are central to the risk of death from COVID-19 in liver transplant recipients, Journal of Hepatology (published online 5 February 2021)
• Ramer, S J, This is Not Happening, Journal of Clinical Oncology (published online 4 February 2021)
• Wilkinson, E, Dramatic drop in new cancer drug trials during the COVID-19 pandemic, The Lancet Oncology (published online 4 February 2021)
• de Jonge, L, et al, on behalf of the COVID-19 and Cancer Global Modelling Consortium working group 2, Impact of the COVID-19 pandemic on faecal immunochemical test-based colorectal cancer screening programmes in Australia, Canada, and the Netherlands: a comparative modelling study, The Lancet Gastroenterology & Hepatology (published online 3 February 2021) 
• Onesti, C E, et al, Expected Medium- and Long-Term Impact of the COVID-19 Outbreak in Oncology, JCO Global Oncology (published online 2 February 2021)
• Paremoer, L, Sulakshana, N, et al, Covid-19 pandemic and the social determinants of health, BMJ (published online 29 January 2021)
• Lamont, E B, et al, Trends in Oncology Clinical Trials Launched Before and During the COVID-19 Pandemic, JAMA Network Open (published online 27 January 2021) 
• Islam, J Y, et al, Evaluating Mental Health-Related Symptoms Among Cancer Survivors During the COVID-19 Pandemic: An Analysis of the COVID Impact Survey, JCO Oncology Practice (published online 22 January 2021)
• Spencer, K, et al, The impact of the COVID-19 pandemic on radiotherapy services in England, UK: a population-based study, The Lancet Oncology (published online 22 January 2021)
• Yekedüz, E, et al, Commentary: Should all cancer patients be tested for COVID-19 before each chemotherapy cycle? Journal of Oncology Pharmacy Practice (published online 20 January 2021) (subscriber or paid access only)
• Rogiers, A, et al, Clinical impact of COVID-19 on patients with cancer treated with immune checkpoint inhibition, Journal for ImmunoTherapy of Cancer (published online 19 January 2021) 
• Way, T L, et al, Social restrictions during COVID‐19 and major trauma volume at a level 1 trauma centre, MJA, (published online 18 January 2021)
• Bakouny, Z, et al, Cancer Screening Tests and Cancer Diagnoses During the COVID-19 Pandemic, JAMA Oncology (published online 14 January 2021)
• Chhabra, A M, et al, A National Survey of Radiation Oncology Experiences Completing Tele-Consultations During the Coronavirus Disease (COVID-19) Pandemic, Advances in Radiation Oncology (published online 13 January 2021)
• Rajan, S, et al, Searching for answers: Cancer care during the COVID pandemic, Clinical Epidemiology and Global Health (published online 13 January 2021)
• Yeoh, Y K, et al, Gut microbiota composition reflects disease severity and dysfunctional immune responses in patients with COVID-19, Gut (published online 11 January 2021)
• Tan, W S, et al, Major Urological Cancer Surgery for Patients is Safe and Surgical Training Should Be Encouraged During the COVID-19 Pandemic: A Multicentre Analysis of 30-day Outcomes, European Urology Open Science (published online 9 January 2021)
• Berlin, A, et al, Implementation and Outcomes of Virtual Care Across a Tertiary Cancer Center During COVID-19, JAMA Oncology (published online 7 January 2021)
• Rosenquist, J N, The Stress of Bayesian Medicine — Uncomfortable Uncertainty in the Face of Covid-19, New England Journal of Medicine (published online 7 January 2021)
• Newman, L A, et al, Similarities in Risk for COVID-19 and Cancer Disparities, Clinical Cancer Research (published online January 2021)
• Yackzan, S, and Mahon, S M, COVID-19 Pandemic 101: An Epidemiology and Public Health Primer for Oncology Nurses, Clinical Journal of Oncology Nursing (2021, 25(1), 33-40) (subscriber or paid access only)
• Duncan, R, et al, Care and Coping During COVID-19: Practice Changes and Innovations in the Oncology Setting, Clinical Journal of Oncology Nursing (2021, 25(1), 48-55) (subscriber or paid access only)

• Vijenthira, A, et al, Outcomes of patients with hematologic malignancies and COVID-19: a systematic review and meta-analysis of 3377 patients, Blood (2020)
• Burki, T K, Cuts in cancer research funding due to COVID-19, The Lancet Oncology (published online 17 December 2020)
• Leong, T L, Delayed access to lung cancer screening and treatment during the COVID‐19 pandemic: Are we headed for a lung cancer pandemic? Respirology (published online 15 December 2020)
• Desai, A, et al, Use of Real-World Electronic Health Records to Estimate Risk, Risk Factors, and Disparities for COVID-19 in Patients With Cancer, JAMA Oncology (published online 10 December 2020)
• Rubin, E J, et al, SARS-CoV-2 Vaccination – An Ounce (Actually, Much Less) of Prevention, New England Journal of Medicine (published online 10 December 2020)
• Feletto, E, et al, How has COVID-19 impacted cancer screening? Adaptation of services and the future outlook in Australia, Public Health Research Practice (published online 9 December 2020)
• Sutherland, K, et al, Impact of COVID-19 on healthcare activity in NSW, Australia, Public Health Research & Practice (published online 9 December 2020)
• Eley, D S, et al, Is Australia’s clinician scientist capacity appropriate for addressing the next pandemic? Australian Health Review (published online 8 December 2020)
• Pennell, N A, et al, American Society of Clinical Oncology Road to Recovery Report: Learning From the COVID-19 Experience to Improve Clinical Research and Cancer Care, Journal of Clinical Oncology (published online 8 December 2020)
• Fanciullino, R, et al, COVID-19 vaccine race: watch your step for cancer patients, British Journal of Cancer (published online 7 December 2020)
• Haase, K R, et al, Older survivors of cancer in the COVID-19 pandemic: Reflections and recommendations for future care, Journal of Geriatric Oncology (published online 3 December 2020)
• Han, H J, et al, COVID-19 and cancer: From basic mechanisms to vaccine development using nanotechnology, International Immunopharmacology (published online 2 December 2020)
• WHO Ad Hoc Expert Group on the Next Steps for COVID-19 Vaccine Evaluation, Placebo-Controlled Trials of COVID-19 Vaccines — Why We Still Need Them, NEJM, (published online 2 December 2020)
• WHO Solidarity Trial Consortium, Repurposed Antiviral Drugs for Covid-19 – Interim WHO Solidarity Trial Results, NEJM (published online 2 December 2020) 
• Bouleftour, W, et al, Impact of COVID-19 outbreak through telemedicine implementation on data reporting during oncology clinical trials, Cancer Investigation (published online 1 December 2020)
• Chazan, G, Franchini, F, Alexander, M, et al, Impact of COVID-19 on cancer service delivery: results from an international survey of oncology clinicians, ESMO Open (published online 1 December 2020)
• Engelhardt, M, et al, Clinical characteristics and outcome of multiple myeloma patients with concomitant COVID-19 at Comprehensive Cancer Centers in Germany, Haematologica (published online December 2020) 
• Patt D, et al, Impact of COVID-19 on Cancer Care: How the Pandemic Is Delaying Cancer Diagnosis and Treatment for American Seniors, JCO Clinical Cancer Informatics (published online 30 November 2020)
• Clark, J J, et al, The effect of clinical decision making for initiation of systemic anticancer treatments in response to the COVID-19 pandemic in England: a retrospective analysis, The Lancet Oncology (published online 27 November 2020)
• Gelderblom, H, et al, COVID-19 and systemic anticancer therapy: exploiting uncertainty, The Lancet Oncology (published online 27 November 2020)
• Sadler, D, et al, Perspectives on the COVID-19 pandemic impact on cardio-oncology: results from the COVID-19 International Collaborative Network survey, Cardio-Oncology (published online 27 November 2020)
• Chaix, B, et al, Psychological distress during the COVID-19 pandemic in France: a national assessment of at-risk populations, General Psychiatry (published online 26 November 2020) 
• Jammu, A S, et al, Systematic rapid living review of the impact of the COVID-19 pandemic on cancer survivors: update to August 27, 2020, Supportive Care in Cancer (published online 26 November 2020)
• Garde-Noguera, J, et al, Impact of SARS-CoV-2 Infection on Patients with Cancer: Retrospective and Transversal Studies in Spanish Population, Cancers (published online 25 November 2020)
• Duarte, M B O, et al, Outcomes of COVID-19 Patients under Cytotoxic Cancer Chemotherapy in Brazil, Cancers (published online 24 November 2020) 
• Thomaier, L, et al, Emotional health concerns of oncology physicians in the United States: Fallout during the COVID-19 pandemic, PLOS ONE (published online 24 November 2020)
• Wang, L, et al, Clinical challenges in cancer patients with COVID-19: Aging, immunosuppression, and comorbidities, Aging (published online 24 November 2020)
• Cooksley, T, et al, Emerging challenges in the evaluation of fever in cancer patients at risk of febrile neutropenia in the era of COVID-19: a MASCC position paper, Supportive Care in Cancer (published online 23 November 2020)
• Knudsen, K E, et al, Optimizing the use of telemedicine in oncology care: post-pandemic opportunities, Clinical Cancer Research (published online 23 November 2020). SUBSCRIBER/PAID ACCESS ONLY
• Amicucci, M, et al, The Management of Children with Cancer during the COVID-19 Pandemic: A Rapid Review, Journal of Clinical Medicine (published online 21 November 2020)
• Gundavda, M K & Gundavda, K K, Cancer or COVID-19? A Review of Guidelines for Safe Cancer Care in the Wake of the Pandemic, SN Comprehensive Clinical Medicine (published online 21 November 2020) 
• Morrison, K S, et al, The Feasibility of Exercise Interventions Delivered via Telehealth for People Affected by Cancer: A Rapid Review of the Literature, Seminars in Oncology Nursing (in press published online 20 November 2020). SUBSCRIBER/PAID ACCESS ONLY
• Kaye, R, et al, Digitally-Enabled Remote Care for Cancer Patients: Here to Stay, Seminars in Oncology Nursing (in press published online 19 November 2020). SUBSCRIBER/PAID ACCESS ONLY
• Carrieri, D, and Peccatori, F A, Seeing beyond COVID-19: understanding the impact of the pandemic on oncology, and the importance of preparedness, History and Philosophy of the Life Sciences (published online 18 November 2020)
• Fedele, P, et al, De-escalating cancer treatments during COVID 19 pandemic: Is metronomic chemotherapy a reasonable option? Critical Reviews in Oncology/Hematology (published online 18 November 2020) 
• Gultekin, M, et al, Perspectives, fears and expectations of patients with gynaecological cancers during the COVID-19 pandemic: A Pan-European study of the European Network of Gynaecological Cancer Advocacy Groups (ENGAGe), Cancer Medicine (published online 18 November 2020)
• Gupta, A K, et al, Tobacco use as a well-recognized cause of severe COVID-19 manifestations, Respiratory Medicine (published online 18 November 2020)  
• Zarifkar, P, et al, Clinical Characteristics and Outcomes in Patients with COVID-19 and Cancer: a Systematic Review and Meta-analysis, Clinical Oncology (published online 18 November 2020)
• Lai, A G, et al, Estimated impact of the COVID-19 pandemic on cancer services and excess 1-year mortality in people with cancer and multimorbidity: near real-time data on cancer care, cancer deaths and a population-based cohort study, BMJ Open (published online 17 November 2020)
• Rezende, L F M, et al, Physical activity for cancer patients during COVID-19 pandemic: a call to action, Cancer Causes & Control (published online 16 November 2020)
• Buising, K L, et al, A hospital‐wide response to multiple outbreaks of COVID‐19 in health care workers: lessons learned from the field, MJA (published online 15 November 2020)
• Levine, O H, et al, Virtual Cancer Care During the COVID-19 Pandemic and Beyond: A Call for Evaluation, JMIR Cancer (online ahead of print 12 November 2020)
• Baldassarre, L A, et al, Cardiovascular care of the oncology patient during COVID-19: An expert consensus document from the ACC Cardio-Oncology and Imaging Councils, Journal of the National Cancer Institute (published online 12 November 2020)
• Fleury M E, et al, Association of the COVID-19 Outbreak With Patient Willingness to Enroll in Cancer Clinical Trials, JAMA Oncology (published online 12 November 2020) 
• Dalu, D, et al, A proposal of a "ready to use" COVID-19 control strategy in an Oncology ward: Utopia or reality? Critical Reviews in Oncology/Hematology (published online 11 November 2020) 
• Chen, H, et al, Differences in terms of presentation and outcomes between patients with lung cancer as opposed to other solid organ cancer after infection with SARS-CoV-2: protocol for a systematic review, BMJ Open (published online 10 November 2020)
• Quagliariello, V, et al, SARS-CoV-2 Infection and Cardioncology: From Cardiometabolic Risk Factors to Outcomes in Cancer Patients, Cancers (published 10 November 2020)
• Beigel, JH, et al, Remdesivir for the Treatment of Covid-19 — Final Report, New England Journal of Medicine (published online 5 November 2020)
• Celum, C, et al, Covid-19, Ebola, and HIV — Leveraging Lessons to Maximize Impact, New England Journal of Medicine (published online 5 November 2020)
• Hanna, T P, et al, Mortality due to cancer treatment delay: systematic review and meta-analysis, BMJ (published online 4 November 2020)
• Song, H, et al, Disruptions in preventive care: Mammograms during the COVID-19 pandemic, Health Services Research (published online 4 November 2020)
• Schmidt, A L, et al, Cancer Care Disparities during the COVID-19 Pandemic: COVID-19 and Cancer Outcomes Study, Cancer Cell (published online 3 November 2020)
• Banerjee, R, and Prasad V, Pragmatic trials with prespecified subgroups: what oncologists can learn from COVID-19, Nature Reviews Clinical Oncology (published online 2 November 2020)
• Park, R, et al, Association of active oncologic treatment and risk of death in cancer patients with COVID-19: a systematic review and meta-analysis of patient data, Acta Oncologica (published online 2 November 2020)
• Zhang, H, et al, Clinical Characteristics and Outcomes of COVID-19-Infected Cancer Patients: A Systematic Review and Meta-Analysis, Journal of the National Cancer Institute (published online 2 November 2020)
• Ramaswamy, A, et al, COVID-19 in cancer patients on active systemic therapy – Outcomes from LMIC scenario with an emphasis on need for active treatment, Cancer Medicine (published online 31 October 2020)
• Miranda, RR, et al, Head and neck cancer therapy-related oral manifestation management in the COVID-19 pandemic: a critical review, Brazilian Oral Research (published online 30 October 2020)
• Amaddeo, G, et al, Impact of COVID-19 on the management of hepatocellular carcinoma in a high-prevalence area, Journal of Hepatology (published online 29 October 2020) 
• Hernandez, J L, et al, Vitamin D Status in Hospitalized Patients with SARS-CoV-2 Infection, Journal of Clinical Endocrinology & Metabolism (published online 27 October 2020)
• Mian, BM, et al, Management of urologic cancers during the pandemic and potential impact of treatment deferrals on outcomes, Urologic Oncology: Seminars and Original Investigations (published online 28 October 2020
• Ioannidis, J P A, and Jha, P, Does the COVID-19 pandemic provide an opportunity to eliminate the tobacco industry? The Lancet Global Health (published online 26 October 2020)
• Crolley, V E, et al, COVID-19 in cancer patients on systemic anti-cancer therapies: outcomes from the CAPITOL (COVID-19 Cancer PatIenT Outcomes in North London) cohort study, Therapeutic Advances in Medical Oncology (published online 23 October 2020)
• Greenwood, E, and Swanton, C, Consequences of COVID-19 for cancer care – a CRUK perspective, Nature Reviews Clinical Oncology (published online 23 October 2020)
• Ray, U, et al, COVID-19: The Impact in Oncology Care, SN Comprehensive Clinical Medicine (published online 23 October 2020)
• Sigorski, D, et al, Impact of COVID-19 on anxiety levels among patients with cancer actively treated with systemic therapy, ESMO Open (published online 23 October 2020)
• Agarwal, A, Mukherjee, A, et al, on behalf of the PLACID Trial Collaborators, Convalescent plasma in the management of moderate covid-19 in adults in India: open label phase II multicentre randomised controlled trial (PLACID Trial), BMJ (published online 22 October 2020)
• Rodin, D, et al, The reality of virtual care: Implications for cancer care beyond the pandemic, Healthcare (published online 22 October 2020)
• Corley, D A, et al, Cancer Screening during COVID-19: A Perspective from NCI's PROSPR consortium, Gastroenterology (published online 21 October 2020) 
• Heriot, G S, Jamrozik, E, Not in my backyard? COVID-19 vaccine development requires someone to be infected somewhere, MJA (preprint 21 October 2020)
• Marra, A, et al, Seroconversion in patients with cancer and oncology healthcare workers infected by SARS-CoV-2, Annals of Oncology (published online 21 October 2020) 
• Boon, I S, et al, Digital healthcare and shifting equipoise in radiation oncology: The butterfly effect of the COVID-19 pandemic, Journal of Medical Imaging and Radiation Sciences (published online 20 October 2020)
• Davey Smith, G, COVID-19’s known unknowns, BMJ (published online 19 October 2020)
• Holt, N R, et al, Implications of COVID‐19 for an ageing population, MJA (published online 19 October 2020)
• Ferriss, J S, et al, Society of Gynecologic Oncology recommendations for fellowship education during the COVID-19 pandemic and beyond: Innovating programs to optimize trainee success, Gynecologic Oncology (published online 17 October 2020)
• Janda, M, Paul, C, Horsham, C, for the PoCoG Cancer Prevention Special Interest Group, Changes in cancer preventive behaviours, screening and diagnosis during COVID-19, Psycho-Oncology (published online 16 October 2020)
• Norman, M L, et al, Stay at home: implementation and impact of virtualising cancer genetic services during COVID-19, Journal of Medical Genetics (published online 16 October 2020)
• Alwan, N A, et al, Scientific consensus on the COVID-19 pandemic: we need to act now, The Lancet (published online 15 October 2020)
• Way, T, et al, The effect of COVID-19 social restrictions on major trauma volumes and resource utilisation at a level 1 trauma centre, Medical Journal of Australia (preprint published online 15 October 2020) 
• Grewal, U S, et al, Tele-health and Palliative Care for Cancer Patients: Implications for the COVID-19 Pandemic, JMIR Cancer (forthcoming/in press published online 14 October 2020) 
• Forster, V J, et al, Unique needs of childhood cancer survivors during the COVID-19 pandemic, Supportive Care in Cancer (published online 14 October 2020) 
• Leiter, R E, Reentry, NEJM (published online 14 October 2020)
• Shapiro, J, and McDonald, T B, Supporting Clinicians during Covid-19 and Beyond — Learning from Past Failures and Envisioning New Strategies, NEJM (published online 14 October 2020)
• Park, E R, et al, Impact of the COVID-19 pandemic on telehealth research in cancer prevention and care: A call to sustain telehealth advances, Cancer (published online 13 October 2020)
• Fedele, P, et al, Exploring metastatic breast cancer treatment changes during COVID-19 pandemic, Journal of Chemotherapy (published online 13 October 2020)
• Osterman, C K, et al, Risk stratification and outreach to hematology/oncology patients during the COVID-19 pandemic, Supportive Care in Cancer (published online 12 October 2020)
• Ramachandran, P, et al, COVID-19 in Cancer Patients From New York City: A Comparative Single Center Retrospective Analysis, Cancer Control (published online 12 October 2020)
• Song, C, et al, An online tool for predicting the prognosis of cancer patients with SARS-CoV-2 infection: a multi-center study, Journal of Cancer Research and Clinical Oncology (published online 11 October 2020) 
• Bakhribah, H, et al, Implications of COVID-19 pandemic on lung cancer management: A multidisciplinary perspective, Critical Reviews in Oncology/Haematology (published 10 October 2020) 
• Lu, D J, et al, Evaluation of mobile health applications to track patient-reported outcomes for oncology patients: A systematic review, Advances in Radiation Oncology (published online 9 October 2020)
• Beigel, J H, et al, Remdesivir for the Treatment of COVID-19 — Final Report, NEJM (published online 8 October 2020)
• Blumenthal, D, et al, Covid-19 — Implications for the Health Care System, New England Journal of Medicine (published online 8 October 2020)
• North, C M, et al, Improving Clinical Trial Enrollment — In the Covid-19 Era and Beyond, New England Journal of Medicine (published online 8 October 2020)
• Al-Tabba, A, et al, Ethical Considerations for Treating Cancer Patients During the SARS-CoV-2 Virus Crisis: To Treat or Not to Treat? A Literature Review and Perspective From a Cancer Center in Low-Middle Income Country, Frontiers in Medicine (published online 7 October 2020)
• De Felice, F, et al, A snapshot on radiotherapy for head and neck cancer patients during the COVID-19 pandemic: a survey of the Italian Association of Radiotherapy and Clinical Oncology (AIRO) head and neck working group, Radiology (published online 6 October 2020)
• Gatti, M, et al, The Complex Management of Atrial Fibrillation and Cancer in the COVID-19 Era: Drug Interactions, Thromboembolic Risk, and Proarrhythmia, Current Heart Failure Reports (published online 6 October 2020)
• Geonka, A, et al, Implementation of Telehealth in Radiation Oncology: Rapid Integration During COVID-19 and its Future Role in our Practice, Advances in Radiation Oncology (published online 8 October 2020)
• Helissey, C, et al, Evaluation of medical practices in oncology in the context of the COVID‐19 pandemic in France: Physicians’ point of view: the PRATICOVID study, Cancer Medicine (published online 6 October 2020)
• Sim, A J, et al, Harnessing COVID-Driven Technical Innovations for Improved Multi-Disciplinary Cancer Care in the Post-COVID Era: The Virtual Patient Room, Cancer Control (published online 6 October 2020)
• Datta, S S, et al, Addressing the Mental Health Challenges of Cancer Care Workers in LMICs During the Time of the COVID-19 Pandemic, JCO Global Oncology (published online 5 October 2020)
• Stanaway, F, et al, COVID-19: how many Australians might have died if we’d had an outbreak like that in England and Wales? Medical Journal of Australia (preprint published online 5 October 2020) 
• Hawkes, C, Five steps towards a global reset: lessons from COVID-19, Cambridge University Press (published online 2 October 2020)
• Janiaud P, et al, The worldwide clinical trial research response to the COVID-19 pandemic – the first 100 days [version 1; peer review: 2 approved], F1000Research (published online 2 Oct 2020)
• Lopez, P, et al, Can Exercise Adaptations Be Maintained in Men with Prostate Cancer Following Supervised Programmes? Implications to the COVID-19 Landscape of Urology and Clinical Exercise, European Urology Open Science (published online 2 October 2020)
• Bakouny, Z, et al, COVID-19 and Cancer: Current Challenges and Perspectives, Cancer Cell (published online 1 October 2020)
• Bland, K A, et al, Exercising in Isolation? The Role of Telehealth in Exercise Oncology During the COVID-19 Pandemic and Beyond, Physical Therapy (October 2020); vol 100, issue 10, pages 1713–1716
• Helm, E E, et al, Effect of Disrupted Rehabilitation Services on Distress and Quality of Life in Breast Cancer Survivors During the COVID-19 Pandemic, Rehabilitation Oncology (October 2020)
• Chitwood, H, How Does an Oncology Nurse Increase Moral Resilience During a Pandemic? Clinical Journal of Oncology Nursing (October 2020)
• Knoll, M A, et al, Virtual Connectivity During Quarantine: The Role of Social Media for Radiation Oncology During COVID-19, International Journal of Radiation Oncology (October 2020); vol 108, issue 2, pp506-508
• Hall, E, et al, Life After COVID-19 for Cancer Clinical Trials, International Journal of Radiation Oncology (October 2020); vol 108, issue 2, pp486-488
• Siker, M L, et al, Lessons From COVID-19: Addressing Health Equity in Cancer Care, International Journal of Radiation Oncology (October 2020); vol 108, issue 2, pp475-478
• Coles, C E, et al, COVID-19: A Catalyst for Change for UK Clinical Oncology, International Journal of Radiation Oncology (October 2020); vol 108, issue 2, pp462-465
• Ting, FI, et al, COVID-19 in cancer patients can be challenging to screen in a resource limited setting, Cancer Treatment and Research Communications (published online 29 September 2020)
• Helfand, B K I, et al, The Exclusion of Older Persons From Vaccine and Treatment Trials for Coronavirus Disease 2019 — Missing the Target, JAMA Internal Medicine (published online 28 September 2020) 
• Jazieh, A R, et al, Impact of the COVID-19 Pandemic on Cancer Care: A Global Collaborative Study, JCO Global Oncology (published online 28 September 2020); no 6 (2020) 1428-1438
• Zazzara, M B, et al, Probable delirium is a presenting symptom of COVID-19 in frail, older adults: a cohort study of 322 hospitalised and 535 community-based older adults, Age and Ageing (published online 28 September 2020)
• Horton, R, Offline: COVID-19 is not a pandemic, The Lancet (published online 26 September 2020)
• Islam, J Y, et al, Examining COVID-19 Preventive Behaviors among Cancer Survivors in the United States: an analysis of the COVID-19 Impact Survey, Cancer Epidemiology Biomarkers & Prevention (published online 25 September 2020)
• Burki, T K, Burnout among cancer professionals during COVID-19, The Lancet Oncology (published online 24 September 2020)
• McLoone, J, et al, The COVID‐19 pandemic: Distance‐delivered care for childhood cancer survivors, Pediatic Blood and Cancer (published online 24 September 2020)
• Schwartz, J L, Evaluating and Deploying Covid-19 Vaccines – The Importance of Transparency, Scientific Integrity, and Public Trust, New England Journal of Medicine (Perspective, published online 23 September 2020) 
• Disis, M, Oncology and COVID-19, JAMA (Viewpoint, 22-29 September 2020)
• Tolaney, S M, et al, The Impact of COVID-19 on Clinical Trial Execution at the Dana-Farber Cancer Institute, Journal of the National Cancer Institute (published online 22 September 2020)
• Beslija, S, Managing an oncology clinic during the COVID-19 pandemic – how we did it in Sarajevo? Magazine of European Medical Oncology (published online 21 September 2020) 
• Franco, I, et al, Improving Diversity and Inclusion in the Post-COVID Era through a Radiation Oncology Intensive Shadowing Experience (RISE), Advances in Radiation Oncology (published online 21 September 2020)
• Giesen, N, et al, Evidence-based management of COVID-19 in cancer patients: Guideline by the Infectious Diseases Working Party (AGIHO) of the German Society for Haematology and Medical Oncology (DGHO), European Journal of Cancer (published online 21 September 2020)
• Hilbe, W, et al, Creating the “new normal” post-Coronavirus world – web-communication replacing face-to-face interaction, Magazine of European Medical Oncology (published online 21 September 2020)
• Veronesi, P, Corso, G, Impact of COVID-19 pandemic on clinical and surgical breast cancer management, E Clinical Medicine (published online 20 September 2020)
• American Association for Cancer Research, Repurposing Cancer Drugs for COVID-19, Cancer Discovery (News in Depth published online 18 September 2020)
• Krok-Schoen, J L, et al, Experiences of healthcare providers of older adults with cancer during the COVID-19 pandemic, Journal of Geriatric Oncology (published online 18 September 2020) 
• Upadhaya, S, et al, Immuno-oncology drug development forges on despite COVID-19, Nature Reviews Drug Discovery (published online 18 September 2020)
• Currie, G, et al, COVID-19 impact on undergraduate teaching: Medical radiation science teaching team experience, Journal of Medical Imaging and Radiation Sciences (published 17 September 2020)
• Bersanelli, M, et al, Clinical impact of COVID-19 in a single-center cohort of a prospective study in cancer patients receiving immunotherapy, Future Medicine (published online 15 September 2020)
• Westblade, L F, et al, SARS-CoV-2 Viral Load Predicts Mortality in Patients with and Without Cancer Who Are Hospitalized with COVID-19, Cancer Cell (published online 15 September 2020) 
• Tran, T H, et al, Interpreting the effect of social restrictions on cases of COVID-19 using mobility data, Medical Journal of Australia (preprint published online 14 September 2020)
• Kourie, H P, et al, Bioethical considerations for cancer patients care during the COVID-19 pandemic, Future Medicine (published online 9 September 2020)
• Pinar, U, Anract, J, Perrot, O, et al, Preliminary assessment of patient and physician satisfaction with the use of teleconsultation in urology during the COVID-19 pandemic, World Journal of Urology (published online 9 September 2020)
• Watson, M, et al, COVID-19, cancer and psycho-oncology: Dealing with the challenges, Psycho-Oncology (published online 9 September 2020)
• Mannelli, G, et al, Will a tumor pandemic come after the COVID-19 pandemic? Head and Neck cancer perspective, European Review for Medical and Pharmacological Science (8 September 2020)
• Horsley, P J, et al, Radiation oncology during COVID‐19: Strategies to avoid compromised care, Asia-Pacific Journal of Clinical Oncology (published online 7 September 2020)
• Shirke, M M, Shaikh, S A, Harky, A, Implications of Telemedicine in Oncology during the COVID-19 Pandemic, Acta Bio Medica (published online 7 September 2020)
• Thibaudin, M, et al, Immunological features of coronavirus disease 2019 in patients with cancer, European Journal of Cancer (published online 7 September 2020)
• Wallis, C J D, et al, The Impact of the COVID-19 Pandemic on Genitourinary Cancer Care: Re-envisioning the Future, European Urology (published online 4 September 2020)
• Meyer, M, et al, The ongoing COVID-19 pandemic will create a disease surge among cancer patients, ecancer (published online 2 September 2020) 
• Cancer Discovery, COVID-19 Challenges Status Quo for Cancer Care (News in Brief, 1 September 2020)
• Raghavan, D, et al, Management changes for patients with endocrine-related cancers in the COVID-19 pandemic, Endocrine-related Cancer, vol 27 ppR357-R374 (September 2020)
• Shaban, R Z et al, SARS-CoV-2 infection and COVID-19: The lived experience and perceptions of patients in isolation and care in an Australian healthcare setting, American Journal of Infection Control (published online 1 September 2020) 
• Tzeng, C W D, et al, Surgical decision-making and prioritization for cancer patients at the onset of the COVID-19 pandemic: A multidisciplinary approach, Surgical Oncology 34 (September 2020); pp182-185
• Odei, B, and Quick, A, The implications of COVID-19 in radiation oncology in the United States, Current Oncology (published online 31 August 2020)
• Self, W H, Tenforde, M W, Stubblefield, W B, et al, Seroprevalence of SARS-CoV-2 Among Frontline Health Care Personnel in a Multistate Hospital Network — 13 Academic Medical Centers, April–June 2020, Morbidity and Mortality Weekly Report (of the CDC) (published online 31 August 2020)
• Rallis, K S, and Tejerina, A M A, Tele-oncology in the COVID-19 Era: Are Medical Students Left Behind? Trends in Cancer (letter published online 27 August 2020)
• Lee, K A, et al, Cancer and Risk of COVID‐19 Through a General Community Survey, The Oncologist Global Health and Cancer (published online 26 August 2020)
• Jones, N R, et al, Two metres or one: what is the evidence for physical distancing in covid-19? BMJ (published online 25 August 2020) 
• Nekkanti, S S, et al, Mandatory preoperative COVID‐19 testing for cancer patients – Is it justified? Journal of Surgical Oncology (published online 25 August 2020)
• Kosel, K C, and Nash, D B, Connected Communities of Care in Times of Crisis, NEJM Catalyst (commentary published online 24 August 2020)
• Larson, C, et al, COVID-19 and cancer: A guide with suggested COVID-19 rule-out criteria to support clinical decision-making, BBA Reviews on Cancer (published online 20 August 2020) 
• Lyons, A, et al, Early oral cancer management during the COVID-19 period, British Journal of Oral and Maxillofacial Surgery (published online 18 August 2020) 
• Miaskowski, C, et al, Oncology patients’ perceptions of and experiences with COVID-19, Supportive Care in Cancer (published online 18 August 2020)
• Crooks, K, et al, First Nations peoples leading the way in COVID‐19 pandemic planning, response and management, Medical Journal of Australia (published online 17 August 2020) 
• Tong, A, et al, for the COVID-19 Core Outcomes Set Workshop Investigators, Core Outcomes Set for Trials in People With Coronavirus Disease 2019, Critical Care Medicine (published online 17 August 2020)
• Price, S J, Joannides, A, Plaha, P, et al, on behalf of the COVID-CNSMDT study group, Impact of COVID-19 pandemic on surgical neuro-oncology multi-disciplinary team decision making: a national survey (COVID-CNSMDT Study), BMJ Open 2020;10:e040898 (published online 16 August 2020)
• Wong, Z W, and Cross, H L, Telehealth in cancer care during the COVID‐19 pandemic, MJA (published online 16 August 2020)
• Barba, M, et al, Cancer patients and coronavirus disease 2019: evidence in context, Journal of Translational Medicine 18, 315 (2020) (published online 15 August 2020)
• Ismaili, N, COVID-19 Recommendations for Patients with Cancer: The post-COVID-19 Era, SN Comprehensive Clinical Medicine (published online 15 August 2020)  
• Berghoff, A S, et al, SARS-CoV-2 Testing in Patients With Cancer Treated at a Tertiary Care Hospital During the COVID-19 Pandemic, Journal of Clinical Oncology (published online 14 August 2020)
• Brown, S A, et al, Innovation in Precision Cardio-Oncology During the Coronavirus Pandemic and Into a Post-pandemic World, Frontiers in Cardiovascular Medicine (published online 14 August 2020) 
• Balogun, O D, et al, Disparities in Cancer Outcomes Due to COVID-19—A Tale of 2 Cities, JAMA Oncol (published online 13 August 2020)
• Dee, E C, et al, Relative Timing of Radiotherapy and Androgen Deprivation for Prostate Cancer and Implications for Treatment During the COVID-19 Pandemic, JAMA Oncology (published online 13 August 2020)
• Rubinstein, S M, and Warner, J L, COVID-19 and haematological malignancy: navigating a narrow strait, The Lancet Haematology (published online 13 August 2020)
• Passamonti, F, et al, Clinical characteristics and risk factors associated with COVID-19 severity in patients with haematological malignancies in Italy: a retrospective, multicentre, cohort study, The Lancet Haematology (published online 13 August 2020) 
• Brochez, L, et al, Recommendations for skin cancer consultation and surgery during COVID‐19 pandemic, Journal of the European Academy of Dermatology and Venereology (published online 12 August 2020)
• Nemeth, K, et al, Scoping review on the prevalence of cancer in COVID‐19 patients, British Journal of Surgery (published online 10 August 2020)
• Ferrari, A, et al, Experiencing Social Isolation (Even in the Era of COVID-19 Pandemic Lockdown): Teachings Through Arts from Adolescents with Cancer, Journal of Adolescent and Young Adult Oncology (published online 7 August 2020)
• Tartarone, A, and Lerose, R, COVID-19 and cancer care: what do international guidelines say? Medical Oncology (published online 7 August 2020)
• Chamilos, G, et al, Are all patients with cancer at heightened risk for severe Coronavirus Disease 2019 (COVID-19)? Clinical Infectious Diseases (published online 7 August 2020)
• Ji, C, et al, Is Elective Cancer Surgery Safe During the COVID-19 Pandemic? World Journal of Surgery (published online 6 August 2020)
• Urun, Y, et al, Survey of the Impact of COVID-19 on Oncologists’ Decision Making in Cancer, JCO Global Oncology (published online 5 August 2020)
• de las Heras, B, et al, Cancer Treatment and Research During the COVID-19 Pandemic: Experience of the First 6 Months, Oncology and Therapy (published online 4 August 2020) 
• Kaufman, H W, et al, Changes in the Number of US Patients With Newly Identified Cancer Before and During the Coronavirus Disease 2019 (COVID-19) Pandemic, JAMA Network Open (published online 4 August 2020)
• Mulvey, T M, et al, COVID-19 and Cancer Care: Ensuring Safety While Transforming Care Delivery, Journal of Clinical Oncology (published online 4 August 2020)
• Yin, K, et al, Breast imaging, breast surgery, and cancer genetics in the age of COVID‐19, Cancer (published online 4 August 2020)
• Lam, K, et al, Assessing Telemedicine Unreadiness Among Older Adults in the United States During the COVID-19 Pandemic, JAMA Intern Med (published online 3 August 2020) 
• Kanjanapan, Y, and Yip, D, Considerations for cancer immunotherapy during the COVID-19 pandemic, Medical Journal of Australia (published online 3 August 2020)
• Martinelli, F, Garbi, A, Change in practice in gynecologic oncology during the COVID-19 pandemic: a social media survey, International Journal of Gynecologic Cancer 2020;30:1101-1107 (published online 3 August 2020)
• Burki, T, The indirect impact of COVID-19 on women, The Lancet Infectious Diseases (August 2020)
• Shuman, AG, et al, COVID-19 and Drug Shortages: A Call to Action, Journal of Managed Care & Specialty Pharmacy (August 2020)
• Curigliano, G, et al, Managing cancer patients during the COVID-19 pandemic: An ESMO Interdisciplinary Expert Consensus, Annals of Oncology (published online 31 July 2020)
• ElGohary, G, The risk and prognosis of COVID-19 infection in cancer patients: A systematic review and meta-analysis, Hematology/Oncology and Stem Cell Therapy (published online 31 July 2020)
• Freedman, T S, et al, Lessons of COVID-19: A roadmap for post-pandemic science, Journal of Experimental Medicine (2020) 217 (9): e20201276 (published online 31 July 2020)
• Marron, J M, et al, Waging War on War Metaphors in Cancer and COVID-19, JCO Oncology Practice (published online 31 July 2020)
• Wang, Y, et al, Epidemiology of mental health problems among patients with cancer during COVID-19 pandemic, Translational Psychiatry (published online 31 July 2020)
• Milch, V, et al, Cancer Australia's Response to the COVID-19 Pandemic, Clinical Oncology (published online 29 July 2020)
• Izmailov, A, et al, Management strategy for cancer patients in the context of the COVID-19 epidemic, Seminars in Oncology (published online 28 July 2020) 
• Newby, J M, et al, Acute mental health responses during the COVID-19 pandemic in Australia, PLOS ONE (published online 28 July 2020)
• Addison, D, et al, Cardio‐Oncology in Era of the COVID‐19 Pandemic and Beyond, Journal of the American Heart Association (published online 27 July 2020)
• London, J W, et al, Effects of the COVID-19 Pandemic on Cancer-Related Patient Encounters, JOC Clinical Cancer Informatics (published online 27 July 2020)
• Whittemore, P B, COVID-19 fatalities, Latitude, sunlight, and vitamin D, American Journal of Infection Control (published online 26 June 2020)
• Yashadhana, A, et al, Indigenous Australians at increased risk of COVID-19 due to existing health and socioeconomic inequities, The Lancet Regional Health (published online 24 July 2020)
• Blumenthal, D, et al, Covid-19 — Implications for the Health Care System, New England Journal of Medicine (published online 22 July 2020)
• Li, Q, Hwang, L C, Strategies for selecting/switching chemotherapy and supportive care treatments during COVID‐19 outbreak, Cancer Medicine (published online 20 July 2020)
• Maringe, C, et al, The impact of the COVID-19 pandemic on cancer deaths due to delays in diagnosis in England, UK: a national, population-based, modelling study, The Lancet Oncology (published online 20 July 2020)
• Karacin, C, et al, How does COVID-19 fear and anxiety affect chemotherapy adherence in patients with cancer, Future Oncology (published online 17 July 2020)
• RECOVERY Collaborative Group, Dexamethasone in Hospitalized Patients with Covid-19 — Preliminary Report, New England Journal of Medicine (published online 17 July 2020)
• Lane, H C, and Fauci, A S, Research in the Context of a Pandemic, New England Journal of Medicine (editorial, published online 17 July 2020)
• Tuech, J, et al, The Day after Tomorrow: How Should We Address Health System Organization to Treat Cancer Patients after the Peak of the COVID-19 Epidemic? Oncology (published online ahead of print 17 July 2020)
• Battisti, N, et al, Adapting care for older cancer patients during the COVID-19 pandemic: Recommendations from the International Society of Geriatric Oncology (SIOG) COVID-19 Working Group, Journal of Geriatric Oncology (published online 16 July 2020)
• Garg, P K, et al, Discordance of COVID‐19 guidelines for patients with cancer: A systematic review, Journal of Surgical Oncology (published online 15 July 2020)
• Gupta, S, et al, Factors Associated with Death in Critically Ill Patients with Coronavirus Disease 2019 in the US, JAMA Internal Medicine (published online 15 July 2020)
• North, C, et al, Improving Clinical Trial Enrollment — In the Covid-19 Era and Beyond, New England Journal of Medicine (published online 15 July 2020)
• Lakin, J R, ACP-PEACE Investigators, et al, Advance Care Planning: Promoting Effective and Aligned Communication in the Elderly (ACP-PEACE): the study protocol for a pragmatic stepped-wedge trial of older patients with cancer, BMJ Open (published online 14 July 2020)
• Shad, M A, et al, Hematology and oncology clinical care during the coronavirus disease 2019 pandemic, Cancer (published online 14 July 2020)
• Guven, D C, et al, COVID-19 pandemic: changes in cancer admissions, BMJ Supportive & Palliative Care (published online 14 July 2020)
• Garutti, M, et al, Seven Shades of Black Thoughts: COVID-19 and Its Psychological Consequences on Cancer Patients, Frontiers in Oncology (published online 10 July 2020)
• Carfi A, et al, Persistent Symptoms in Patients After Acute COVID-19, JAMA (published online 9 July 2020)
• Chochinov, H, et al, Death, Dying, and Dignity in the Time of the COVID-19 Pandemic, Journal of Palliative Medicine (editorial, published online 9 July 2020)
• Kang, J J, et al, The 3 B's of Cancer Care Amid the COVID-19 Pandemic Crisis: "Be Safe, Be Smart, Be Kind" – A Multidisciplinary Approach Increasing the Use of Radiation and Embracing Telemedicine for Head and Neck Cancer, Cancer, (published online 8 July 2020)
• Smrke, A, et al, Telemedicine During the COVID-19 Pandemic: Impact on Care for Rare Cancers, JCO Global Oncology, no 6 (2020) 1046-1051 (published online 8 July 2020)
• Helsper, C W, et al, Cancer has not gone away: A primary care perspective to support a balanced approach for timely cancer diagnosis during COVID‐19, European Journal of Cancer Care (commentary, published online 7 July 2020)
• Faux, S G, et al, COVID‐19: planning for the aftermath to manage the aftershocks, Medical Journal of Australia (perspectives, published online 6 July 2020)
• Olabumuyi, A A, et al, Oncology practice in the COVID-19 pandemic: a report of a Nigerian expert panel discussion (oncology care in Nigeria during the COVID-19 pandemic), Pan African Medical Journal, 2020;36:152 (6 July 2020)
• Pańczyk, P, et al, Maintaining physical activity in the era of COVID-19 pandemic: a chair-based exercise program for home-isolated elderly prostate cancer patients, Central European Journal of Urology (published online 6 July 2020)
• de Joode K, et al, Impact of the coronavirus disease 2019 pandemic on cancer treatment: the patients' perspective, European Journal of Cancer (published online ahead of print 4 July 2020)
• Assi, T, et al, Screening Strategies for COVID-19 in Patients With Hematologic Malignancies, Frontiers in Oncology (published online 3 July 2020)
• Young, AM, et al, Uncertainty upon uncertainty: Supportive Care for Cancer and COVID-19, Support Care Cancer (published online 2 July 2020); 28, 4001–4004
• Gyawali, B, et al, COVID-19 Pandemic – An Opportunity to Reduce and Eliminate Low-Value Practices in Oncology? JAMA Oncology (published online 2 July 2020)
• Spring, L M, et al, Case 22-2020: A 62-Year-Old Woman with Early Breast Cancer during the Covid-19 Pandemic, New England Journal of Medicine (1 July 2020)
• Said, C M, et al, Physical Activity and Exercise for Older People During and After the Coronavirus Disease 2019 Pandemic: A Path to Recovery, JADMA, vol 21, pp977-979 (July 2020)
• Tan, A C, Ashley, D M, and Khasraw, M, Adapting to a Pandemic — Conducting Oncology Trials during the SARS-CoV-2 Pandemic, Clinical Cancer Research (published online July 2020) 
• Newton, R, et al, Keeping Patients With Cancer Exercising in the Age of COVID-19, JCO Oncology Practice (published online 30 June 2020)
• Ramanan, M, et al, An evaluation of the quality and impact of the global research response to the COVID-19 pandemic, Medical Journal of Australia (published online ahead of print 30 June 2020)
• Rhee, J, et al, Dying still matters in the age of COVID-19, Australian Journal of General Practice 2020 (published online ahead of print 30 June 2020)
• Sheng, J Y, et al, Management of Breast Cancer During the COVID-19 Pandemic: A Stage- and Subtype-Specific Approach, JCO Oncology Practice (published online 30 June 2020)
• Halpern, S, et al, Cognitive Bias and Public Health Policy During the COVID-19 Pandemic, JAMA, 2020;324(4):337-338 (published online 29 June 2020)
• Koczwara, B, Cancer survivorship care at the time of the COVID‐19 pandemic, MJA (published online 28 June 2020)
• Wang, E, et al. The International Response to the Coronavirus Disease (2019) COVID-19 Pandemic in Radiation Oncology, Advances in Radiation Oncology (published online 28 June 2020)
• Frey, M, et al, Impact of the COVID-19 Pandemic on Quality of Life for Women With Ovarian Cancer, American Journal of Obstetrics and Gynecology (published online ahead of print 26 June 2020)
• Guzman, R, et al, Dual Challenge of Cancer and COVID-19: Impact on Health Care and Socioeconomic Systems in Asia Pacific, JCO Global Oncology (published online 26 June 2020) 
• Shalowitz, D I, et al, Principles of ethics and critical communication during the COVID-19 pandemic, Gynecologic Oncology (in press, published online 25 June 2020)
• Melidis, C, et al, Ethical and practical considerations on cancer recommendations during COVID 19 pandemic, Molecular and Clinical Oncology (published online 24 June 2020)
• Gupta, A, Plans and Pandemics, New England Journal of Medicine (perspective, published online 23 June 2020)
• Slimano, F, et al, Cancer, Immune Suppression and Coronavirus Disease-19 (COVID-19): Need to Manage Drug Safety (French Society for Oncology Pharmacy [SFPO] Guidelines), Cancer Treatment Reviews (23 June 2020)
• Unwins, C, et al, COVID-19 and Gynecological Cancer: A Review of the Published Guidelines, International Journal of Gynecologic Cancer (published online ahead of print 23 June 2020)
• Anderson, N, et al, Planning for a pandemic: Mitigating risk to radiation therapy service delivery in the COVID‐19 era, Journal of Medical Radiation Science (published online 22 June 2020)
• Lee, L, et al, COVID-19 mortality in patients with cancer on chemotherapy or other anticancer treatments: a prospective cohort study, The Lancet, vol 395, no 10241, pp1919-1926 (20 June 2020)
• Wainstein, A J A, et al, Risks of COVID‐19 for surgical cancer patients: The importance of the informed consent process, Journal of Surgical Oncology (published online 20 June 2020)
• Ciążyńska, M, et al, Quality of life of cancer patients during coronavirus disease (COVID-19) pandemic, Psycho-Oncology (published online 17 June 2020)
• Ghosh, J, et al, Perspective of Oncology Patients During COVID-19 Pandemic: A Prospective Observational Study From India, JCO Global Oncology (published online 17 June 2020) 
• Gasper, H, et al, COVID-19 and the cancer care workforce: From doctors to ancillary staff, Seminars in Oncology (published online ahead of print 16 June 2020)
• Wang, B, et al, Which type of cancer patients are more susceptible to the SARS-COX-2: Evidence from a meta-analysis and bioinformatics analysis, Critical Reviews in Oncology/Hematology (published online 15 June 2020)
• Naeem, S B, and Bhatti, R, The COVID‐19 ‘infodemic’: a new front for information professionals, Health Information and Libraries Journal (published online 13 June 2020)
• Deroose, C M, et al, Impact of the COVID-19 crisis on imaging in oncological trials, European Journal of Nuclear Medicine and Molecular Imaging (editorial, published online, 12 June 2020)
• Moujaess, E, et al, Targeted therapies for cancer during the COVID-19 pandemic: a threat or a blessing? Future Medicine (editorial, published online 10 June 2020)
• Joharatnam-Hogan, N, et al, COVID-19 cancer conundrum – evidence driving decisions or the lack of it? BMC Medicine (commentary, published online 9 June 2020)
• Perner, A, et al, How likely are COVID-19 interventions to benefit the sickest patients? Intensive Care Medicine (editorial, published online 9 June 2020)
• Michel, L, et al, Oncocardiology: new challenges, new opportunities, Herz (published online 8 June 2020)
• Sharma, A, et al, Severity and risk of COVID‐19 in cancer patients: An evidence based learning, Dermatologic Therapy (published online 8 June 2020)
• Flannigan, R, et al, Pearls to pivoting a multidisciplinary prostate cancer survivorship program during the COVID-19 pandemic, European Urology Oncology (in press, published online 5 June 2020)
• Wong, S W and Cross, H L, Telehealth in cancer during COVID-19 pandemic, Medical Journal of Australia (preprint published online 1 June 2020)
• Wong, R Y, Medical education during COVID-19: Lessons from a pandemic. Key lessons learned during COVID-19 at the UBC Faculty of Medicine, BC Medical Journal, vol 62, no 5, pp170-171, Special Feature COVID-19 (June 2020) 
• Rottenberg, Y, et al, Geriatric patient-centered care during the COVID-19: Provision of interactions vs. the imposition of isolation, Journal of Geriatric Oncology (in press, June 2020)
• Indini, A, et al, Developing a risk assessment score for patients with cancer during the coronavirus disease 2019 pandemic, European Journal of Cancer (published online 31 May 2020)
• Degeling, K, et al, An inverse stage-shift model to estimate the excess mortality and health economic impact of delayed access to cancer services due to the COVID-19 pandemic, medRxiv (preprint published online 30 May 2020)
• Doherty, G J, et al, Rethinking cancer clinical trials for COVID-19 and beyond, Nature Cancer 1, 568–572 (published online 29 May 2020) 
• Koczwara, B, At the time of the pandemic cancer survivors are getting lost in transition, Medical Journal of Australia (preprint, published online 29 May 2020)
• Kuderer, N M, et al, Clinical impact of COVID-19 on patients with cancer (CCC19): a cohort study, The Lancet (published online 28 May 2020)
• Shirke, M M, Shaikh, S A, Harky, A, Tele-oncology in the COVID-19 Era: The Way Forward? Trends in Cancer (published online 26 May 2020)
• Singh, A P, et al, Management of lung cancer during the COVID-19 pandemic, JCO Oncology Practice (published online 26 May 2020)
• Chan, A, et al, Cancer survivorship care during COVID-19—perspectives and recommendations from the MASCC survivorship study group, Support Care Cancer (published online 25 May 2020)
• Docherty, A B, et al, Features of 20 133 UK patients in hospital with covid-19 using the ISARIC WHO Clinical Characterisation Protocol: prospective observational cohort study, British Medical Journal (published online 22 May 2020)
• Tsang, Y, et al, Meeting the challenges imposed by COVID-19: Guidance document by the ESTRO Radiation TherapisT Committee (RTTC), Technical Innovations & Patient Support in Radiation Oncology (published online 22 May 2020)
• Di Lorenzo, G, et al, COVID-19 therapies and anti-cancer drugs: A systematic review of recent literature, Critical Reviews in Oncology/Hematology (published online ahead of publication, 21 May 2020)
• Hotez, J, COVID19 meets the antivaccine movement, Microbes Infect (editorial published online 19 May 2020)
• Nilsen M L, et al, Prevision of multidisciplinary head and neck prevention survivorship care during the 2019 novel coronavirus pandemic, Head & Neck (published online 18 May 2020)
• Ofori-Asenso, R, et al, Cancer is associated with severe disease in COVID-19 patients: a systematic review and meta-analysis, ecancer (research published online 18 May 2020)
• Livio, B, et al, Reactions and countermeasures of medical oncologists towards the incoming COVID-19 pandemic: a WhatsApp messenger-based report from the Italian College of Chief Medical Oncologists, ecancer (research, published online 15 May 2020)
• Boulad, F, et al, COVID-19 in Children with Cancer in New York City, JAMA Oncology (research letter, published online 13 May 2020)
• Verdoni, L, et al, An outbreak of severe Kawasaki-like disease at the Italian epicentre of the SARS-CoV-2 epidemic: an observational cohort study, The Lancet (published 13 May 2020)
• Mohile, S, et al, Perspectives from the Cancer and Aging Research Group: Caring for the vulnerable older patient with cancer and their caregivers during the COVID-19 crisis in the United States, Journal of Geriatric Oncology (in press, published online 10 May 2020)
• Gosain, R, et al, COVID-19 and Cancer: a Comprehensive Review, Current Oncology Reports (8 May 2020)
• Shah, S K, et al, Ethics of controlled human infection to study COVID-19, Science (policy forum, 7 May 2020)
• Selman, L, et al, Bereavement support on the frontline of COVID-19: Recommendations for hospital clinicians, Journal of Pain and Symptom Management (published online 3 May 2020)
• Marandino, L, et al, COVID-19 Emergency and the Need to Speed Up the Adoption of Electronic Patient-Reported Outcomes in Cancer Clinical Practice, JCO Oncology Practice (editorial, published online 1 May 2020)
• Metha, V, et al, Case Fatality Rate of Cancer Patients with COVID-19 in a New York Hospital System, Cancer Discovery (published online 1 May 2020) 
• Simcock, R, et al, COVID-19: Global radiation oncology’s targeted response for pandemic preparedness, Clinical and Translational Radiation Oncology, vol 22, pp88-89 (May 2020)
• Davis, A P, et al, COVID-19: the use of immunotherapy in metastatic lung cancer, Future Medicine (comment, published online ahead of print 30 April 2020)
• Kostarelos, K, Nanoscale nights of COVID-19, Nature Nanotechnology (thesis, published 27 April 2020)
• Nekhlyudov, L, et al, Addressing the needs of cancer survivors during the COVID-19 pandemic, Journal of Cancer Survivorship (editorial, 25 April 2020)
• Mazzone, P J, et al, Management of Lung Nodules and Lung Cancer Screening During the COVID-19 Pandemic: CHEST Expert Panel Report, Radiology: Imaging Cancer (published online 23 April 2020)
• Mayor, S, COVID-19: impact on cancer workforce and delivery of care, The Lancet Oncology (news, published online 20 April 2020)
• Warish, A, et al, First confirmed detection of SARS-CoV-2 in untreated wastewater in Australia: A proof of concept for the wastewater surveillance of COVID-19 in the community, Science of the Total Environment (published online 18 April 2020)
• Holmes, E, et al, Multidisciplinary research priorities for the COVID-19 pandemic: a call for action for mental health science, Lancet Psychiatry (position paper, published online 15 April 2020)
• Bajwah, S, et al, Managing the supportive care needs of those affected by COVID-19, European Respiratory Journal (editorial, published online 7 April 2020)
• Ueda, M, et al, Managing Cancer Care During the COVID-19 Pandemic: Agility and Collaboration Toward a Common Goal, Journal of the National Comprehensive Cancer Center Network, vol 18, no 4 (published online April 2020)
• McDermott, M, and Newman, A, Preserving Clinical Trial Integrity During the Coronavirus Pandemic, JAMA (opinion, published online 25 March 2020)